000 01829 a2200469 4500
005 20250513110127.0
264 0 _c19970408
008 199704s 0 0 eng d
022 _a0895-7061
024 7 _a10.1016/S0895-7061(96)00253-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParan, E
245 0 0 _aThe effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
_h[electronic resource]
260 _bAmerican journal of hypertension
_cDec 1996
300 _a1206-13 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdrenergic beta-Antagonists
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xadministration & dosage
650 0 4 _aAtenolol
_xadministration & dosage
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCaptopril
_xadministration & dosage
650 0 4 _aDiuretics
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aHydrochlorothiazide
_xadministration & dosage
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPropranolol
_xadministration & dosage
650 0 4 _aQuality of Life
650 0 4 _aSodium Chloride Symporter Inhibitors
_xadministration & dosage
650 0 4 _aSurveys and Questionnaires
700 1 _aAnson, O
700 1 _aNeumann, L
773 0 _tAmerican journal of hypertension
_gvol. 9
_gno. 12 Pt 1
_gp. 1206-13
856 4 0 _uhttps://doi.org/10.1016/S0895-7061(96)00253-1
_zAvailable from publisher's website
999 _c8964605
_d8964605